v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2021
Mar. 31, 2020
CURRENT ASSETS    
Cash $ 9,861,575 $ 9,604,780
Accounts receivable 149,082 206,729
Prepaid expenses and other current assets 341,081 229,604
TOTAL CURRENT ASSETS 10,351,738 10,041,113
Property and equipment, net 160,976 140,484
Right-of-use lease asset 40,363 136,426
Patents, net 56,954 57,504
Restricted cash 46,726 0
Deposits 12,159 12,159
TOTAL ASSETS 10,668,916 10,387,686
CURRENT LIABILITIES    
Accounts payable 337,678 285,036
Due to related parties 118,520 111,707
Deferred revenue 114,849 100,000
Lease liability, current portion 42,543 98,557
Other current liabilities 761,636 472,420
TOTAL CURRENT LIABILITIES 1,375,226 1,067,720
Lease liability, less current portion 0 42,540
TOTAL LIABILITIES 1,375,226 1,110,260
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2021 and 2020; 12,150,597 and 9,366,873 issued and outstanding at March 31, 2021 and 2020, respectively 12,152 9,368
Additional paid-in capital 129,331,542 121,426,563
Accumulated deficit (119,913,090) (112,026,381)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 9,430,604 9,409,550
NONCONTROLLING INTERESTS (136,914) (132,124)
TOTAL STOCKHOLDERS' EQUITY 9,293,690 9,277,426
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 10,668,916 $ 10,387,686

Source